International Journal of Cancer Management
The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Immunotoxin therapy: a promising frontier in targeted cancer treatment a review of clinical trials in hematological and solid tumors
Cancer Treatment and Research Communications
2026
Abdi A.
Open Access
Design of recombinant bacteriocin fusion protein and evaluation of its anticancer and antibacterial activity
Microbial Pathogenesis
August 2025
Yadollahi N.
Unlocking the potential of tumor-targeting peptides in precision oncology
Oncology Research
2025
Rehman H.M.
Open Access
Design and computational analysis of a novel Leptulipin-p28 fusion protein as a multitarget anticancer therapy in breast cancer
Toxicology Research
1 October 2024
Khalid S.
All Open Access, Green
A novel EGFR-specific recombinant ricin-panitumumab (scFv) immunotoxin against breast and colorectal cancer cell lines; in silico and in vitro analyses
European Journal of Pharmacology
15 September 2023
Naemi A.A.
Computational design of a chimeric toxin against Claudin-4-expressing cancer cells: molecular modeling, docking and molecular dynamics simulation analysis
Veterinary Research Forum
May 2023
Safaei S.
Synthesis of ruthenium polypyridine complexes with benzyloxyl groups and their antibacterial activities against Staphylococcus aureus
Journal of Inorganic Biochemistry
November 2022
Wang R.
Molecular dynamics simulations, docking and MMGBSA studies of newly designed peptide-conjugated glucosyloxy stilbene derivatives with tumor cell receptors
Molecular Diversity
October 2022
Rico M.I.
Bacteria-derived chimeric toxins as potential anticancer agents
Frontiers in Oncology
7 September 2022
Khoshnood S.
Open Access
Design of two immunotoxins based rovalpituzumab antibody against DLL3 receptor; A promising potential opportunity
Research in Pharmaceutical Sciences
July-August 2022
Ataee M.
Open Access
Design and evaluation of scFv-RTX-A as a novel immunotoxin for breast cancer treatment: an in silico approach
Journal of Immunoassay and Immunochemistry
2021
Samavarchi Tehrani S.
Breast cancer targeted/ therapeutic with double and triple fusion Immunotoxins
Journal of Steroid Biochemistry and Molecular Biology
June 2020
Goleij Z.
Open Access
Bioinformatics Predictions, Expression, Purification and Structural Analysis of the PE38KDEL-scfv Immunotoxin Against EPHA2 Receptor
International Journal of Peptide Research and Therapeutics
1 June 2020
Rezaie E.
A new scfv-based recombinant immunotoxin against EPHA2-overexpressing breast cancer cells; High in vitro anti-cancer potency
European Journal of Pharmacology
5 March 2020
Rezaie E.
In silico design and evaluation of scFv-CdtB as a novel immunotoxin for breast cancer treatment
International Journal of Cancer Management
January 2020
Vafadar A.
Open Access